About 

The Consortium for Autoimmune Liver Diseases (CALiD) consists of North American researchers and patient advocates with interests and expertise in the study and treatment of autoimmune liver diseases, including but not limited to primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis.  Major decisions are made by the Steering Committee with input from members and other stakeholders including industry, funding agencies, regulatory agencies, and patient advocacy groups.

STEERING COMMITTEE MEMBERS

Christopher L. Bowlus, M.D. (Chair)
Division of Gastroenterology and Hepatology School of Medicine
University of California Davis
 
David Assis, MD
Section of Digestive Diseases
Yale University School of Medicine
 
Mark Deneau, MD
Division of Pediatric Gastroenterology
University of Utah
 
David Goldberg, MD
Division of Gastroenterology and Hepatology
University of Pennsylvania
​
Cynthia Levy, MD
Division of Hepatology
University of Miami
 
Kidist K. Yimam, M.D.
Division of Hepatology and Liver Transplantation
California Pacific Medical Center